Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New MDMA Board Chairman Chavez Will Tackle User Fee, GPO Issues

This article was originally published in The Gray Sheet

Executive Summary

Securing adequate funds to implement the device user fee program and monitoring the business practices of group purchasing organizations will remain the top priorities for the Medical Device Manufacturers Association in the coming year, according to outgoing board chairman Paul Touhey

You may also be interested in...



MDMA board of directors

Dynatronics Corp. President and CEO Kelvyn Cullimore, New Enterprise Associates Partner Ryan Drant and Advanced Medical Optics Corporate VP Russell Trenary join Medical Device Manufacturers Association board. Chris Chavez, president and CEO of Advanced Neuromodulation Systems, was elected chairman in June (1"The Gray Sheet" June 9, 2003, p. 5)...

What Lies Ahead: COVID-19 Vaccination Challenges

The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel